Real-time continuous glucose monitoring (rtCGM) devices provide important advances in blood glucose monitoring technology, facilitating recognition of patient-specific trends of hyper- and hypoglycemia. rtCGM is now being evaluated and utilized in a variety of settings and conditions, including primary care, outpatient, and in-hospital settings, and in conditions such as type 1 diabetes, type 2 diabetes, and pregnancy. Join our diabetes experts as they discuss the evolution and increasing role of CGM in the hospital, in type 2 diabetes, and pregnancy. The 90-minute live symposium will also be simultaneously streamed live for online attendees, who will have an opportunity to participate in a 2-way conversation with faculty. Attendees will be able to ask questions related to the content to the faculty in both settings.
You must be logged in and own this session in order to